Pamela Glendinning

I am so excited to be working with Sean Pihl of Pihl Law Corporation to bring you a free seminar on Addiction and Mental Illness in the Workplace.  The other keynote speakers are Lisa Murray of Profectus Consulting, Suzi Beckett of Empire Life and myself.  The invitation is attached, please let us know if you…

I am always happy to be a Sponsor of the HRMA Mingles.  On October 7th we had the mingle at the Delta Grand Hotel which is now part of the Merritt Hotel chain.  They did an outstanding job with the food, and the presentation on the diverse Human Resources they work with daily. Thank you for…

Two weeks ago I started a series of Blogs on The Headache of Enrolling an Employee Late.  I wanted to remind everyone how important it is to ensure that employees are added to the Employee Benefit Program within 30 days of the end of the Waiting Period. The below is an article out of “Smallbiz…

Last week I started a series of Blogs on The Headache of Enrolling an Employee Late.  I wanted to remind everyone how important it is to ensure that employees are added to the Employee Benefit Program within 30 days of the end of the Waiting Period. The below is an article out of “Smallbiz Advisor“:…

I wanted to remind everyone how important it is to ensure that employees are added to the Employee Benefit Program within 30 days of the end of the Waiting Period. The below is an article out of "Smallbiz Advisor": The Headache of Late Applicants BY Joe Demelo, TRG Benefits Group | February 26, 2013 Does…

As a broker my job is be informed of options for my clients, and present them.  The job of the client is to ensure that they choose the option that best works for their Company and Employees. Health Care Spending Accounts (HCSA) can help control the ongoing costs of benefit programs, but is not the solution…

The Financial Post wrote about Martin Shkreli who increased the cost of the drug Daraprim by 5,000%.  This drug is used for people who suffer from HIV.  His reason for the increase was the company is not profitable and he wants to use the profits to do more research.  He apparently wants to make the drug safer with less side…